Convergence Insufficiency Treatment Trial: Attention and Reading Trial (CITT-ART)

The purpose of the CITT-ART study is to evaluate the effects of office-based therapy with home reinforcement on reading and attention outcomes for children with symptomatic Convergence Insufficiency (CI), a vision disorder. Children with symptomatic CI report significantly more symptoms when reading and doing close work (e.g., blurred vision, headaches, double vision, loss of concentration, frequent loss of place, trouble remembering what was read), have more behaviors that lead to academic difficulties (e.g., difficulty finishing assignments), and score worse on parent ratings of attention compared to children with normal binocular vision. There is evidence that the symptoms and adverse academic behaviors associated with CI can be reduced through treatment. The CITT-ART study tests the hypothesis that reducing or eliminating these symptoms and behaviors will lead to improved reading performance and attention.

Principal Investigator:

Mitchell Scheiman, Salus University, Carolyn Denton, PhD, University of Texas Health Science Center at Houston (UTHealth Houston)

Participating Sites:

Advanced Vision Center, Schaumburg, IL

Akron Children’s Hospital, Akron, OH

Bascom Palmer Eye Institute, University of Miami, Miami, FL

Marshall B Ketchum University, Fullerton, CA

Nova Southeastern University, Fort Lauderdale, FL

Ohio State University, Columbus, OH

Salus University, Pittsburgh, PA

State University of New York, New York, NY

University of Alabama School of Medicine at Birmingham, Birmingham, AL

University of Texas Health Science Center at Houston (UTHealth Houston), Houston, TX

Western University of Health Sciences, Pomona, CA